Nippon India Pharma Fund Direct-IDCW Payout
NAV
₹183.5252
as on 18 Sep 2024, 11:11 PM
₹-2.0851(1.12%)
Last Change
Scheme Information
Nippon India Pharma Fund Direct-IDCW Payout
as of 31 Aug 2024, 05:30 AM
₹8,647.95 Cr
0.91%
2.59%
Open-End
Growth
Exit load of 1% if redeemed within 1 month.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
97.41%
₹8,423.96 Cr
Others
2.59%
₹223.98 Cr
Healthcare
97.41%
₹8,423.96 Cr
Others
2.59%
₹223.98 Cr
Sun Pharmaceutical Industries Ltd.
13.47%
₹1,164.88 Cr
Divi's Laboratories Ltd.
8.39%
₹725.56 Cr
Lupin Ltd.
7.67%
₹663.30 Cr
Cipla Ltd.
6.20%
₹536.17 Cr
Dr. Reddy's Laboratories Ltd.
6.05%
₹523.20 Cr
Others
58.22%
₹5,034.83 Cr
Sun Pharmaceutical Industries Ltd.
13.47%
₹1,164.88 Cr
Divi's Laboratories Ltd.
8.39%
₹725.56 Cr
Lupin Ltd.
7.67%
₹663.30 Cr
Cipla Ltd.
6.20%
₹536.17 Cr
Dr. Reddy's Laboratories Ltd.
6.05%
₹523.20 Cr
Others
58.22%
₹5,034.83 Cr
Funds in this Category
This fund's returns: 19.21%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
23.01
Category Returns
15.00%
23.01%
3Y Returns
23.01 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
22.05
Category Returns
15.00%
23.01%
3Y Returns
22.05 %
Tata India Pharma & HealthCare Fund Direct-Growth
Min. Investment
₹100
21.46
Category Returns
15.00%
23.01%
3Y Returns
21.46 %
About Nippon India Pharma Fund Direct-IDCW Payout
Nippon India Pharma Fund Direct-IDCW Payout scheme return performance in last 1 year is 48.28%, in last 3 years is 69.59% and 721.69% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
AUM: | ₹8,647.95 Cr |
Category: | Equity: Sectoral-Pharma |
Launch Date: | Invalid date |
Fund Type: | Open-End |
AMC Information
Nippon India Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹1,65,036
₹1,69,586
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹69,586
69.59%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk